arrow
H

Heike Peterziel

hopp children's cancer center heidelberg
H指数:30
被引数:2,548

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cytotoxic activity of selinexor in BRAFV600E-driven pediatric low-grade glioma 3D cultures

塞利尼索对BRAFV600E驱动的儿童低级别胶质瘤3D培养物的细胞毒性活性

2026-10-220
OAAI
CpG hypermethylation and WNT/AP-1 cooperativity define the epigenetic landscape and a clinical subgroup of high-risk pediatric adrenocortical carcinoma

CpG超甲基化与WNT/AP-1协同作用定义了表观遗传景观及高风险儿科肾上腺皮质癌的一个临床亚组

2026-09-140
OAAI
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach

室管膜瘤组特异性血脑屏障差异的多组学方法揭示

2026-04-100
OAAI
Preclinical drug screen identifies WEE1 inhibitor and vinca alkaloid as a combination treatment concept for Li-Fraumeni syndrome medulloblastoma
2025-12-290
OAAI
High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma

高4E-BP1表达与染色体8获得及CDK4/6敏感性在尤因肉瘤中相关联

2025-12-150
OA
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas

高内涵成像药物协同筛选鉴定间充质神经母细胞瘤特异性的衰老相关易损性

2025-08-250
OAAI
LEVERAGING ABERRANT EXTRACELLULAR VESICLE SIGNALING FOR TARGETED DRUG REPURPOSING IN PEDIATRIC EPENDYMOMA
2024-06-180
OAAI
DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM
2023-06-120
OAAI